Search Medical Condition
Narcolepsy Clinical Trials
A listing of Narcolepsy medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found (22) clinical trials
Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy
The purpose of this study is to determine whether FT218 is safe and effective for the treatment of excessive daytime sleepiness and cataplexy in subjects with narcolepsy.
A Double-Blind, Placebo-Controlled, Randomized-Withdrawal, Multicenter Study of the Efficacy and Safety of JZP-258 in Subjects with Narcolepsy with Cataplexy
The 15-006 study is looking at an investigational medication to see how safe it is, and how well it works, in treating cataplexy and excessive daytime sleepiness in people who have narcolepsy with cataplexy. The study will last up to 22 weeks. All study-related medication and assessments will be provided ...
An Open Label Expanded Access Program Intended to Provide Treatment with HBS-101 (Pitolisant) to Adult Patients in the U.S. with Excessive Daytime Sleepiness Associated with Narcolepsy with or without Cataplexy
This program is being conducted to provide access to treatment with Pitolisant to adult patients in the U.S.A. that experience excessive daytime sleepiness associated with narcolepsy with or without cataplexy, while the new drug application for Pitolisant is approved.
Phase 3 Study to Assess the Efficacy and Safety of a Nightly Extended-Release Formulation of Sodium Oxybate for the Treatment of Excessive Daytime Sleepiness and Cataplexy in Subjects with Narcolepsy
This study is double-blind and placebo controlled and intended to assess the efficacy and safety of a once nightly formulation of sodium oxybate for extended-release oral suspension (FT218) for the treatment of excessive daytime sleepiness and cataplexy in subjects with narcolepsy. This study will be 14-17 weeks long and requires ...
Phase 3 Study of the Efficacy and Safety of JZP-258 in Subjects with Narcolepsy with Cataplexy
This is an 18-week, double-blind, placebo-controlled study to evaluate the efficacy of JZP-258 in the treatment of cataplexy and excessive daytime sleepiness in subjects with narcolepsy. This study also has an optional 24-week open label extension period.
Neuropathy Study
Do you or a loved one have narcolepsy? Are you interested in taking part in a medication research study for this condition? Wake Research is seeking individuals with narcolepsy to take part in a research study of an investigational medication for this condition.
Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in Narcolepsy
This trial is a randomized, double-blind, placebo-controlled, crossover study to evaluate the effect of JZP-110 on driving performance in subjects with excessive sleepiness due to narcolepsy.
A Study to Evaluate the Safety and Efficacy of TS-091 in Patients With Narcolepsy
The purpose of this study is to investigate the efficacy and safety after administration of TS-091 compared with placebo in patients with narcolepsy.
Exploration of the Reward System by Functional MRI in Narco-cataplexy Patients With and Without REM Sleep Behavior Disorder
Type of study: Prospective, case control study. Number of centers: 3 (Clermont-Ferrand, Vichy and Montlucon) Patients : The study will be performed in 66 subjects (22 PD patients with RBD, 22 PD patients without RBD and 22 healthy volunteers, age-and sex-matched without any contraindications to perform an MRI) Study Performance ...
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
CoRDS collects contact, sociodemographic and health information about participants. This information is entered into CoRDS and linked to a unique coded identifier. Below are some examples of information requested on the Questionnaire that will be entered into CoRDS: Contact information: Name, Mailing Address, Phone Number, Email Address Sociodemographic information: Date ...
